Literature DB >> 2876983

Protein kinase C enhances growth hormone releasing factor (1-40)-stimulated cyclic AMP levels in anterior pituitary. Actions of somatostatin and pertussis toxin.

M J Cronin, S T Summers, M A Sortino, E L Hewlett.   

Abstract

The brain peptide human growth hormone releasing factor (1-40) (GRF), which stimulates adenylate cyclase activity in the anterior pituitary, is the predominant hormone signal for pituitary growth hormone (GH) release. Activators of protein kinase C such as teleocidin and 4 beta-phorbol 12-myristate 13-acetate (PMA) double the cyclic AMP accumulation induced by GRF, with no apparent effect on GRF potency; an inactive 4-alpha-PMA has no such action in cultured anterior pituitary cells. This PMA potentiation can be measured as early as 60 s, is maximal by 15 min, and wanes such that by 3-4 h there is no such amplifying effect of PMA. PMA, phorbol 12,13-dibutyrate, and teleocidin ED50 values for potentiating GRF activity are similar to those obtained for direct protein kinase C activation. The major inhibitory peptide somatostatin reduced both GRF- and GRF + PMA-stimulated cyclic AMP accumulation. Pertussis toxin totally blocked this somatostatin action without affecting the degree of maximal GRF potentiation achieved with PMA. Thus, the pertussis toxin target(s) are required for somatostatin inhibition of the cyclic AMP generating system, but may not be involved in the PMA potentiation of GRF-stimulated cyclic AMP accumulation.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2876983

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  9 in total

1.  Phosphorylation of the spliced variant forms of the recombinant stimulatory guanine-nucleotide-binding regulatory protein (Gs alpha) by protein kinase C.

Authors:  N J Pyne; M Freissmuth; S Palmer
Journal:  Biochem J       Date:  1992-07-01       Impact factor: 3.857

2.  TPA enhances growth hormone (GH) secretion effect of GH-releasing hormone (GHRH) by human gsp-positive pituitary somatotrophinomas.

Authors:  T Lei; X Bai; W Hu; D Xue; X Jiang
Journal:  J Tongji Med Univ       Date:  1999

3.  Bradykinin-dependent activation of adenylate cyclase activity and cyclic AMP accumulation in tracheal smooth muscle occurs via protein kinase C-dependent and -independent pathways.

Authors:  P A Stevens; S Pyne; M Grady; N J Pyne
Journal:  Biochem J       Date:  1994-01-01       Impact factor: 3.857

4.  Dual regulation of cyclic AMP formation by thrombin in HEL cells, a leukaemic cell line with megakaryocytic properties.

Authors:  L F Brass; M J Woolkalis
Journal:  Biochem J       Date:  1992-01-01       Impact factor: 3.857

5.  Secretin stimulates cyclic AMP and inositol trisphosphate production in rat pancreatic acinar tissue by two fully independent mechanisms.

Authors:  E R Trimble; R Bruzzone; T J Biden; C J Meehan; D Andreu; R B Merrifield
Journal:  Proc Natl Acad Sci U S A       Date:  1987-05       Impact factor: 11.205

6.  Up-regulation of high voltage-activated Ca(2+) channels in GC somatotropes after long-term exposure to ghrelin and growth hormone releasing peptide-6.

Authors:  Belisario Dominguez; Traudy Avila; Jorge Flores-Hernandez; Gustavo Lopez-Lopez; Herminia Martinez-Rodriguez; Ricardo Felix; Eduardo Monjaraz
Journal:  Cell Mol Neurobiol       Date:  2008-02-08       Impact factor: 5.046

7.  Phorbol esters enhance the cyclic GMP response of T84 cells to the heat-stable enterotoxin of Escherichia coli (STa).

Authors:  C S Weikel; C L Spann; C P Chambers; J K Crane; J Linden; E L Hewlett
Journal:  Infect Immun       Date:  1990-05       Impact factor: 3.441

8.  Potassium Current Is Not Affected by Long-Term Exposure to Ghrelin or GHRP-6 in Somatotropes GC Cells.

Authors:  Belisario Domínguez Mancera; Eduardo Monjaraz Guzman; Jorge L V Flores-Hernández; Manuel Barrientos Morales; José M Martínez Hernandez; Antonio Hernández Beltran; Patricia Cervantes Acosta
Journal:  J Biophys       Date:  2013-02-24

Review 9.  Somatopause, weaknesses of the therapeutic approaches and the cautious optimism based on experimental ageing studies with soy isoflavones.

Authors:  Vladimir Z Ajdžanovic; Svetlana Trifunovic; Dragana Miljic; Branka Šošic-Jurjevic; Branko Filipovic; Marko Miler; Nataša Ristic; Milica Manojlovic-Stojanoski; Verica Miloševic
Journal:  EXCLI J       Date:  2018-03-21       Impact factor: 4.068

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.